Utilize este identificador para referenciar este registo: https://hdl.handle.net/1822/91239

TítuloOregano essential oil: an effective and non-toxic approach for prevent or treat resistant candida species
Autor(es)Fernandes, Liliana Sousa
Silva, Inês
Blázquez, Elena
Tejada, Ainara
Ribeiro, Artur
Silva, Sónia Carina
Mira, Nuno
Cussó, Lorena
Costa-de-Oliveira, Sofia
Rodrigues, Maria Elisa Costa
Henriques, Mariana
Palavras-chaveVulvovaginal candidiasis
Lactobacillus spp
Phytotherapeutic applications
Vapor phase of essential oil
Keratin nanocapsules
Alternative treatment
Data7-Dez-2023
EditoraUniversidade da Beira Interior (UBI)
CitaçãoFernandes, L.; Silva, Inês; Blázquez, Elena; Tejada, Ainara; Ribeiro, Artur; Silva, Sónia Carina; Mira, Nuno; Cussó, Lorena; Costa-de-Oliveira, Sofia; Rodrigues, M. Elisa; Henriques, Mariana, Oregano essential oil: an effective and non-toxic approach for prevent or treat resistant candida species. Microbiotec23 - Congress of Microbiology and Biotechnology 2023. No. P3.6, Covilhã, Portugal, Dec 07-09, 325-326, 2023.
Resumo(s)Vulvovaginal candidiasis (VVC) is one of the most prevalent vaginal infectious diseases, and the emergence of drug-resistant Candida strains has presented a growing challenge in its treatment. This highlights the urgent need to develop effective and non-toxic alternative treatments. In this context, essential oils (EOs) have emerged as a promising alternative considering low toxicity and high antimicrobial activity. This work is divided into two parts, the first consists of evaluating the effect of the vapor phase of oregano EO (VP-OEO) on biofilms of antifungal-resistant Candida species (Candida albicans and Candida glabrata) quantified by colony forming units enumeration and determine their mode of action by flow cytometry. Interestingly, the VP-EOs has shown to be more effective against Candida growth than their liquid form. Indeed, the results revealed high antifungal activity of VP-OEO against these drug-resistant strains, significantly reducing biofilm formation and mature biofilms, with impact on membrane integrity and metabolic activity of the fungal cells. The second part consists of the design and evaluation of nanoencapsulated OEO (KNP-OEO) as another alternative application of OEO for VVC treatment. These nanoparticles provided stability to OEO and controlled release of the EO. The results demonstrated complete inhibition of C. albicans growth. Moreover, in in vivo assay with BALB/C female mice, a single intravaginal application of KNP-OEO reduced C. albicans growth and preserved a healthy vaginal microbiota, including Lactobacillus species. In conclusion, these studies highlight the promising efficacy of OEO as an alternative for VVC treatment. Both approaches, VP-OEO and OEO-KNP, showed effective antifungal activity against drug-resistant strains while preserving vaginal health. These therapeutic options not only combat antifungal resistance, but also potentially propose a safer option for women's health due to their natural characteristics. However, further research is needed to confirm these promising results and advance the development of these alternative VVC therapies.
TipoResumo em ata de conferência
URIhttps://hdl.handle.net/1822/91239
Versão da editorahttps://microbiotec23.organideia.com/
Arbitragem científicayes
AcessoAcesso aberto
Aparece nas coleções:CEB - Resumos em Livros de Atas / Abstracts in Proceedings

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
document_57708_1.pdf246,98 kBAdobe PDFVer/Abrir

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID